Parameter
| Biomarker | Anti-HSP90α IgG | Full name | Anti-Heat Shock Protein 90 Alpha Immunoglobulin G | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | APS risk assessment |
| Disease | Autoimmune Disease (AD) | Disease Subtypes | / | ||
| Organ | Spleen, thymus, lymphoid tissue | Test Sample / Technology Platform | Plasma, serum (ELISA) | ||
| Pathobiological Mechanisms | Decreased levels in patients with SLE secondary to APS can inhibit platelet activation and regulate immune thrombosis. | ||||
| Clinical Availability Status | Research validation: Both exploratory and confirmatory cohorts have confirmed its association with APS risk. | ||||
| Notes and Dynamics | Evaluation of potential biomarkers for assessing the risk of APS in patients with SLE. | ||||